Chao Wang
Fujian Medical University(CN)The University of Texas MD Anderson Cancer Center(US)Anhui Medical University(CN)Military Hospital(PK)Chuzhou University(CN)Obstetrics and Gynecology Hospital of Fudan University(CN)Union Hospital(CN)
Publications by Year
Research Areas
Hippo pathway signaling and YAP/TAZ, Endometrial and Cervical Cancer Treatments, Adenosine and Purinergic Signaling, Medical Imaging Techniques and Applications, Ovarian cancer diagnosis and treatment
Most-Cited Works
- Verteporfin inhibits YAP function through up-regulating 14-3-3σ sequestering YAP in the cytoplasm.(2016)
- → Verteporfin Inhibits PD-L1 through Autophagy and the STAT1–IRF1–TRIM28 Signaling Axis, Exerting Antitumor Efficacy(2020)105 cited
- → Conservative therapy with metformin plus megestrol acetate for endometrial atypical hyperplasia(2014)68 cited
- → YAP/TAZ-Mediated Upregulation of GAB2 Leads to Increased Sensitivity to Growth Factor–Induced Activation of the PI3K Pathway(2017)59 cited
- YAP/TAZ regulates the insulin signaling via IRS1/2 in endometrial cancer.(2016)
- → Deregulated Gab2 phosphorylation mediates aberrant AKT and STAT3 signaling upon PIK3R1 loss in ovarian cancer(2019)49 cited
- → Clinicopathological Risk Factors for Pelvic Lymph Node Metastasis in Clinical Early-Stage Endometrioid Endometrial Adenocarcinoma(2012)36 cited